- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00841061
Cereals as a Source of Iron for Breastfed Infants (Bfe03B)
February 9, 2009 updated by: National Institutes of Health (NIH)
Breast Feeding and Iron: Comparison of Cereals Fortified With Different Forms of Iron
The purpose of this research study is to determine whether the type of iron in infant cereals makes a differance in how well the cereal helps infants remain free of iron deficiency.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
111
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 weeks to 1 year (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- exclusively breastfed
- birth weight between 2500 and 4200g
- gestational age >36 weeks
Exclusion Criteria:
- supplementing formula
- no iron drops
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Cereal L
Rice cereal with electrolytic iron
|
1/4 a cup of cereal fortified with electrolytic iron per day between the ages of 112 days and 280 days of age
|
|
Active Comparator: Cereal M
Rice cereal with ferrous fumarate
|
1/4 cup of cereal fortified with ferrous fumarate to be fed per day between ages of 112 days and 280 days of age
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
plasma ferritin
Time Frame: 280 days
|
280 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
hemoglobin
Time Frame: 280
|
280
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ekhard E Ziegler, MD, University of Iowa
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2003
Primary Completion (Actual)
May 1, 2006
Study Completion (Actual)
May 1, 2006
Study Registration Dates
First Submitted
February 9, 2009
First Submitted That Met QC Criteria
February 9, 2009
First Posted (Estimate)
February 11, 2009
Study Record Updates
Last Update Posted (Estimate)
February 11, 2009
Last Update Submitted That Met QC Criteria
February 9, 2009
Last Verified
January 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B530500
- HD40315-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.